Don Vandenbord from Revere Asset Management believes that Moderna stock may attract investors interested in AI opportunities. He suggests that the potential for AI-focused investment to enter the biotech sector is significant. This viewpoint could lead to further growth in Moderna's stock, as well as in AI-related investments in biotech.